Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jun 7, 2024
Date Accepted: Apr 9, 2025

The final, peer-reviewed published version of this preprint can be found here:

Analyzing Usage of the Metaverse by Associations of Patients With Prostate Cancer During the 2023 Blue Ribbon Campaign: Cross-Sectional Survey Study

Jo JK, Kim Y, Ha YS, Kim KT, Yoo S, Choi WS, Yang J, Shin J, Kim SI, Kim JH

Analyzing Usage of the Metaverse by Associations of Patients With Prostate Cancer During the 2023 Blue Ribbon Campaign: Cross-Sectional Survey Study

J Med Internet Res 2025;27:e63030

DOI: 10.2196/63030

PMID: 40359001

PMCID: 12117273

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Analyzing Prostate Cancer Patient Association Utilization of the Metaverse during the 2023 Blue Ribbon Campaign: Cross-Sectional Survey Study

  • Jung Ki Jo; 
  • Yeeun Kim; 
  • Yun-Sok Ha; 
  • Kwang Taek Kim; 
  • Sangjun Yoo; 
  • Woo Suk Choi; 
  • Jihye Yang; 
  • Jaeeun Shin; 
  • Sun Il Kim; 
  • Jeong Hyun Kim

ABSTRACT

Background:

It is important to explain early diagnosis and treatment plans to patients due to the different stages that diagnosis is made at and corresponding stage-specific treatment options, as well as the varying prognoses depending on the choices made. While various studies have implemented Metaverse interventions across diverse clinical settings for medical education, there is a lack of publications addressing the implementation and validation of patient education using this technology. This study explored the potential of the metaverse as an educational and informational tool for prostate cancer.

Objective:

This study aimed to measure and analyze participants’ satisfaction and perceptions of the Prostate Cancer Metaverse Patient Association.

Methods:

The study was conducted via questionnaire administered from September 15 to October 20, 2023, during the blue ribbon campaign organized by the Korean Urological Foundation and the Korean Society of Urological Oncology. The questionnaire was designed to assess the effectiveness of utilizing the metaverse to increase awareness of prostate cancer. A total of 119 participants completed the survey within the metaverse space, and their satisfaction and changes in awareness were analyzed.

Results:

Mean educational satisfaction score was 4.17 (±0.65), mean psychological satisfaction score was 4.06 (±0.70), mean overall satisfaction score was 4.12 (±0.72), and mean awareness score was 4.09 (±0.72) out of a possible five points. Statistical analysis revealed significant differences in psychological (4.0 [3.50-4.63] vs 4.50 [4.0-4.56]) and overall aspects (4.0 [3.67-4.83] vs 4.33 [4.0-4.67]) between general population individuals versus patients and caregivers (4.0 [3.33-4.33] vs 4.67[4.0-4.67]).

Conclusions:

Many people appear willing to participate in the metaverse based patient association. These results suggest that using Metaverse for healthcare education and information delivery is a valid way to improve healthcare quality and increase patient engagement. This is an important contribution to the advancement of metaverse technology, expanding its potential applications in healthcare.


 Citation

Please cite as:

Jo JK, Kim Y, Ha YS, Kim KT, Yoo S, Choi WS, Yang J, Shin J, Kim SI, Kim JH

Analyzing Usage of the Metaverse by Associations of Patients With Prostate Cancer During the 2023 Blue Ribbon Campaign: Cross-Sectional Survey Study

J Med Internet Res 2025;27:e63030

DOI: 10.2196/63030

PMID: 40359001

PMCID: 12117273

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.